Department of Plastic Surgery and Hand Surgery, University Hospital Zurich, 8091 Zurich, Switzerland.
Division of Internal Medicine, University Hospital of Zurich, 8091 Zurich, Switzerland.
Int J Mol Sci. 2021 Mar 24;22(7):3313. doi: 10.3390/ijms22073313.
Lipedema is an adipose tissue disorder characterized by the disproportionate increase of subcutaneous fat tissue in the lower and/or upper extremities. The underlying pathomechanism remains unclear and no molecular biomarkers to distinguish the disease exist, leading to a large number of undiagnosed and misdiagnosed patients. To unravel the distinct molecular characteristic of lipedema we performed lipidomic analysis of the adipose tissue and serum of lipedema versus anatomically- and body mass index (BMI)-matched control patients. Both tissue groups showed no significant changes regarding lipid composition. As hyperplastic adipose tissue represents low-grade inflammation, the potential systemic effects on circulating cytokines were evaluated in lipedema and control patients using the Multiplex immunoassay system. Interestingly, increased systemic levels of interleukin 11 ( = 0.03), interleukin 28A ( = 0.04) and interleukin 29 ( = 0.04) were observed. As cytokines can influence metabolic activity, the metabolic phenotype of the stromal vascular fraction was examined, revealing significantly increased mitochondrial respiration in lipedema. In conclusion, despite sharing a comparable lipid profile with healthy adipose tissue, lipedema is characterized by a distinct systemic cytokine profile and metabolic activity of the stromal vascular fraction.
脂肪代谢障碍症是一种脂肪组织疾病,其特征是下肢和/或上肢皮下脂肪组织的不成比例增加。其潜在的发病机制尚不清楚,也没有用于区分该疾病的分子生物标志物,导致大量患者未被诊断或误诊。为了揭示脂肪代谢障碍症的独特分子特征,我们对脂肪代谢障碍症患者与解剖和体重指数(BMI)匹配的对照组患者的脂肪组织和血清进行了脂质组学分析。两组组织的脂质组成均无明显变化。由于增生性脂肪组织代表低度炎症,我们使用多重免疫分析系统评估了脂肪代谢障碍症和对照组患者循环细胞因子的潜在系统影响。有趣的是,观察到白细胞介素 11( = 0.03)、白细胞介素 28A( = 0.04)和白细胞介素 29( = 0.04)的系统水平升高。由于细胞因子会影响代谢活性,我们还检查了基质血管部分的代谢表型,结果显示脂肪代谢障碍症患者的线粒体呼吸明显增加。总之,尽管脂肪代谢障碍症与健康脂肪组织具有相似的脂质谱,但它具有独特的系统性细胞因子谱和基质血管部分的代谢活性。